Congresul Național al Federației Societăților Române de Cancer

ZIUA a-1-a / 4 OCTOMBRIE

---

14:00 - 16:00 - The resident doctor afternoon - Prof. Dr. Rodica Anghel - Prof. Dr. Viorica Nagy 16:00 – 16:30 – Coffee break 16:30 – 18:00 – The resident doctor afternoon Prof. Dr. Rodica Anghel Prof. Dr. Viorica Nagy 18:00 – 20:00 - SRR assembly - SRROM assembly

---

ZIUA a-2-a / 5 OCTOMBRIE

---

08:30 – 09:00 – Opening Ceremony 09:00 – 10:30 – Presidential symposium Chair : Prof. Dr . Rodica Anghel, Dr. Mircea Dediu 09:00 – 09:45 – Inside the immune oncology science – Prof.Dr. Jean Pierre Armand 09:45 – 10:30 – How to sequence the available treatments in metastatic melanoma – Prof. Dirk Schadendorf 10:30 – 11:00 – Sarcomas Orphan Disease - Heterogenous Sub-Entities - Heterogenous Treatments : Prof. Dr. Thomas Brodowicz 11:00 – 11:30 – Coffee break 11:30 – 12:30 – Debate : metastatic RAS wt, right side colon cancer : two perspectives on the best treatment sequence Chair : Conf. Dr. Adina Croitoru Antiangiogenics : Dr. Razvan Curca Anti EGFR – Conf. Dr. Adina Croitoru 12:30 – 13:30 – Early breast cancer diagnosis and radiation therapy procedures RT : Conf . Dr. Laura Rebegea - Minimally invasive procedures in pretherapeutical evaluation and treatment in breast cancer - Dr. Lisencu Carmen 13:30 – 14:30 – Lunch 14:30 – 15:30 Find and aim the target in non small cell lung cancer

Chair: Prof. Tudor Ciuleanu

Speaker: Prof. Lucian Miron, Prof. Tudor Ciuleanu, Dr. Mircea Dediu

15:30-17:00 Gynecologic cancers : state of the art Chair: Prof Dr. Viorica Nagy - Guidelines in the management of cervical carcinoma – Dr. Coza Ovidiu - Progress and controversies in ovarian cancer treatment – Dr. Oana Trifanescu Rare gynecological cancers. Prof Dr. Viorica Nagy 17:00-17:30 – Coffee break 17:30-19:00 – Important issues in the multimodal approach of gastric and colon cancer Chair : Conf. Dr. Calin Cainap Surgical challenges in the treatment of colon cancer –Dr Catalin Vlad Patients selection for surgery using PET/CT - Assoc. Prof. Piciu Doina Optimal adjuvant treatment in gastric cancer- Conf. Dr. Calin Cainap 19:00 Romanian Cancer Societies Federation assembly resident doctor awards

---

ZIUA a-3-a / 6 OCTOMBRIE

---

08:00 - 09:00 > Selected oral presentations Chair: Conf. dr. Laurentia Gales 09:00 - 10:30 > Presidential symposium Chair: Prof. Dr. Michael Untch - 09:00 - 09:45 > Lung cancer : tradition vs innovation : where do we stand ? – Prof. Dr. Tudor Ciuleanu 10:30 - 11:00 > Coffee break 11:00 - 13:00 > Debate Session Chair: Dr. Mircea Dediu - 11:00 - 12:00 > Is pathologic complete remission a reliable endpoint for efficacy in neoadjuvant trials performed in breast cancer ? - Speaker in favor : Prof. Michael Untch - Speaker against : Dr. Mircea Dediu - 12:00 - 13:00 > Debate : The benefit exceeds harms in breast cancer screening - Speaker against : Dr. Mircea Dediu 13:00 - 14:00 > Coffee break 14:00 15:30 > Urogenital cancers : state of the art Chair: Conf. Dr. Gabriel Kacso - Radiation therapy in prostate cancer: does one size fit all ? – Conf. Dr. Gabriel Kacso - Immune therapy - Dr. Lazar Popovic - Renal cancer update - Conf. Dr. Dana Stanculeanu 15:30 - 16:00 > Lunch 16:00 - 17:00 > Innovative systemic approach in gastrointestinal and head and neck tumors Chair: Conf. Dr. Serban Negru - Highlights of immune oncology in gastrointestinal cancer - Conf. Dr. Serban Negru - Innovative approach in systemic treatment in head and neck tumors - Conf. Dr. Laurentia Gales 17:00 - 18:00 > Update in systemic treatment of breast cancer Chair: Conf. Dr. Laurentia Gales - Her 2 positive - Dr. Madalina Draganescu - New trends in the endocrine treatment of advanced breast cancer - Conf. Dr. Laurentia Gales

---

ZIUA a-4-a / 7 OCTOMBRIE

---

9.00 - 10.30 - Optimal diagnosis and multimodal approach in Stage III ( N2) NSCLC Chair: Prof. Dr. Rodica Anghel - Diagnosis: Dr Natalia Motas - Radiation therapy: Prof. Dr. Rodica Anghel - Adjuvant vs neoadjuvant chemotherapy in early stage NSCLC : Dr.Mircea Dediu 10:30 - 11:00 > Coffee break 11:00 - 12:00 > The chaos of immune therapy in first line setting of NSCLC Chair: Prof. Dr. Tudor Ciuleanu - Presenting the chaos - Prof. Dr. Tudor Ciuleanu - Attempting to order - Dr. Mircea Dediu 12:00 - 13:00 > Take home messages from the 5th Conference of the Federation Society of Cancer - Dr. Mircea Dediu - Conf. Dr. Calin Cainap

---

5 Octombrie

---

11:30 – 12:30 > BRCA mutation specific biomarker for targeted therapy in ovarian cancer

• Moderator Conf Dr Dana Lucia Stanculeanu
• Speaker: Prof Dr Tudor Ciuleanu, Dr Dragos Median

12:30 – 13:00 > Contemporary Treatment Strategies in aRCC .Considerations for Patient Management

• Speaker : Prof. Cezary Szczylik (Poland) Prof. Ciuleanu Tudor Eliade

13:00 – 13:30 > Actual challenges in individualizing the treatment for mCRPC patients

• Lector: conf. dr. Gabriel Kacso

13:30 – 14:30 > Lunch 15:30 – 16:30 > A new standard in the treatment of advanced gastric cancer?

• Speakers: Prof dr Tudor Ciuleanu, Conf Dr Laura Mazilu, Dr. Filip Dumitru

16:30 – 17:00 > Centrul Oncologic Sanador. Excelenta in oncologie medicala, radioterapie si medicina nucleara

• Speaker : Dr. Mircea Dediu

17:00 - 17:30 > Coffe break 17:30 – 18:30 > The Art of Innovation makes all the difference

• Moderator: Doctor Mircea Dediu
• Speakeri: Doctor Daniela Grecea, Doctor Larisa Ciule, Doctor Mihai Marinca

---

6 OCTOMBRIE

---

11:00 – 11:30 - Soft tissue sarcoma - a real chanllenge!

• Speakers: Dr. Razvan Ovidiu Curca, Conf. Dr. Lucian Stanculeanu

11:30 – 12:00 New therapeutic paradigm in advanced NSCLC and RCC treatment

• Speakers: Prof. Dr. Tudor Ciuleanu

12:30 – 13:00 - The potential of CDK4/6 inhibition

• Speaker : Conf. Dr. Dana Stanculeanu

13:00 – 14:00 – Lunch 14:00 – 14:30 - From Clinical Trials to Clinical Practice. Implementing new paradigms in stage III NSCLC.

• Speaker : Dr Razvan Curca si Dr Laura Mazilu

14:30 – 15:00 - Role of Vectibix in achieving early tumor shrinkage in mCRC

• Speaker : Dediu Mircea, MD

15:00 – 15:30 - Pembrolizumab as first line option in NSCLC with high PD-L1 expression

• Speaker : Dr. Mircea Dediu

15:30 – 16:00 – Coffee break 16:00 – 16:30 - Redefining therapeutic algorithm in metastatic melanoma

• Speaker : Dr. Larisa Ciule

16:30 – 17:00 - An extra chance for patients with prostate cancer resistant to metastatic castration: Jevtana (Cabazitaxel)

• Speaker : Prof. Dr. Tudor Ciuleanu

17:00 – 17:30 - TALKS on mCRC clinical practice

• Speaker : Dr Razvan Curca, Conf Dr Serban Negru

17:30 – 18:00 - Atezolizumab NSCLC Use of Immunotherapy in NSCLC: Success& Challenges in clinical practice Atezolizumab mUC Immunotherapy: advances in mUC management

• Speaker : Dr Mircea Dediu , Conf dr Laura Mazilu

---

14:30 – 17:00 – Sustinere lucrari

---

• Transformari fundamentale in metabolismul cancerului

Autor : Dr. Maria Iuliana Gruia Analiza proteomică a markerilor moleculari plasmatici ca predictori ai cancerului tiroidian diferențiat Autor : Dr. Ancuţa Elena BACIU

• Brahiterapia cu rată ridicată de doza (BT-HDR) în iradierea sarcomului Kapoși (SK)

Autor : Mădălina CROITORIU, Dr. Ancuța Elena BACIU, Drd. Lucia Elena ENCIU, Dr. Gabriel BARANGĂ, Laurențiu BUSUIOC, Miu Cosmin, Conf. Dr. Xenia Elena BACINSCHI

• Efectele biologice induse de 68Ga - conjugat cu peptide asupra celulelor tumorale experimentale

Autor : Marieta Elena Panait, Antonela Busca, Valentiuna Negoita, Mirela Dumitru, Maria Iuliana Gruia

• BIOLOGICAL EFFECTS OF RUTHENIUM (III) COMPOUNDS ASSOCIATED TO CYCLODEXTRINS IN HUMAN COLORECTAL CANCER

Autor : Mirela Mihaila, Camelia Hotnog, Viviana Roman, Marinela Bostan, Valentina Uivarosi, Lorelei I. Brasoveanu

• TREATMENT MODULATION OF BIOMARKERS ASSOCIATED TO COLON CANCER CELL LINES WITH DIFFERENT P53 MUTATIONAL STATUS

Autor: Camelia Mia Hotnog, Mirela Mihaila, Marinela Bostan, Lorelei Irina Brasoveanu

---

17:00 – 17:30 – Coffee break

---

– Coffee break

---

17:30 – 19:00 – Sustinere lucrari

---

• The expression pattern of HOXA11 AS in cervical cancer precursor lesions

Autor : Iulia V. Iancu, Adrian Albulescu, Alina Fudulu, Adriana Plesa, Irina Huica, Demetra Socolov, Gabriela Anton, Anca Botezatu

• Rarity of rare tumors

Autor : Bondei Irina-Mihaela, Todor Nicolae, Nagy Viorica

• Molecular and cellular heterogeneity in glioblastoma: Which are the implications of patient’s care and treatment selection?

Autor: Ionela Bîzu

• Volumetric Modulated Arc Therapy for Total Marrow Irradiation TMI Experience of Bucharest Amethyst Clinic

Autor : Violeta Ciocâltei, Răducu Popa, Daniela Adam, Nicoleta Guraliuc, Florin Ciubotaru

• Experimental validation of CT density table for dose calculation in radiation treatment planning system

Autor : Schultes Noemi, Dordai Dan, Eva Andrea, Farcasanu Alexandru, Domokos Reka

• Butterfly technique for Intensity-modulated radiation therapy (IMRT) and Volumetric-modulated arc therapy (VMAT) in Hodgkin’s lymphoma: A dosimetric comparison

Autor: Farcasanu Alexandru Stefan; Schultes Noemi; Eva Andrea; Dordai Dan; Zahu Renata; Kacso Gabriel

---